Saltar al contenido
Merck

Obesity Affects HDL Metabolism, Composition and Subclass Distribution.

Biomedicines (2021-03-07)
Julia T Stadler, Sonja Lackner, Sabrina Mörkl, Athina Trakaki, Hubert Scharnagl, Andrea Borenich, Willibald Wonisch, Harald Mangge, Sieglinde Zelzer, Nathalie Meier-Allard, Sandra J Holasek, Gunther Marsche
RESUMEN

Obesity increases the risk of coronary heart disease, partly due to its strong association with atherogenic dyslipidemia, characterized by high triglycerides and low high-density lipoprotein (HDL) cholesterol levels. Functional impairment of HDL may contribute to the increased cardiovascular mortality, but the effect of obesity on composition, structure, and function of HDL is not well understood. Design and Methods: We determined HDL composition, HDL subclass distribution, parameters of HDL function, and activities of most important enzymes involved in lipoprotein remodeling, including lecithin-cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) in relatively young normal weight (n = 26), overweight (n = 22), and obese (n = 20) women. Obesity (body mass index (BMI) ≥ 30) was associated with noticeable changes in LCAT and CETP activities and altered HDL composition, such as decreased apolipoprotein A-I, cholesterol, and phospholipid content, while pro-inflammatory HDL serum amyloid a content was increased. We observed a marked shift towards smaller HDL subclasses in obesity linked to lower anti-oxidative capacity of serum. LCAT activity, HDL subclass distribution, and HDL-cholesterol were associated with soluble leptin receptor, adiponectin, and liver enzyme activities. Of note, most of these alterations were only seen in obese women but not in overweight women. Obesity markedly affects HDL metabolism, composition, and subclass distribution linked to changes in liver and adipose tissue. HDL dysfunction may contribute to increased cardiovascular risk in obesity.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Sandoz 58-035, >98% (HPLC), powder